MaxCyte, Inc.
MXCT
$2.57
$0.2410.30%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
1/25/2025
-
MarketBeat
4/8/2025
-
TipRanks Financial Blog
4/8/2025
-
Zacks Investment Research
4/7/2025
-
Zacks Investment Research
4/5/2025
-
MarketBeat
4/4/2025
-
Zacks Investment Research
4/1/2025
-
TipRanks Financial Blog
3/30/2025
-
Ticker Report
3/28/2025
-
MarketBeat
3/25/2025
-
The Fly
3/21/2025
-
MarketBeat
3/21/2025
-
MarketBeat
3/21/2025
-
MarketBeat
3/20/2025
-
Tickeron - Stocks
3/20/2025
-
MarketBeat
3/19/2025
-
The Fly
3/19/2025
-
TipRanks Financial Blog
3/15/2025
-
SeekingAlpha
3/15/2025
-
Tickeron - Stocks
3/15/2025
-
MarketBeat
3/14/2025
-
MarketBeat
3/13/2025
-
MarketBeat
3/13/2025
-
MarketBeat
3/13/2025
-
Tickeron - Stocks
1/23/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
301 944 1700
Address
9713 Key West Avenue
Rockville, MD 20850
Rockville, MD 20850
Country
Year Founded
Business Description
Sector
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static...
more
